RCKT
ROCKET PHARMACEUTICALS, INC.
Key Financials
Operating Income
$-231747000
↑ 15.2%
Revenue
$0
NaN%
Net Income
$-223123000
↑ 13.8%
Total Assets
$330.4M
↓ 37.4%
Cash & Equivalents
$77.6M
↓ 52.6%
Total Liabilities
$53.2M
↓ 17.4%
EPS (Diluted)
$-2.01
↑ 26.4%
Shareholders' Equity
$277.2M
↓ 40.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 144 | 5/19/2026 | View on SEC |
| 144 | 5/19/2026 | View on SEC |
| 144 | 5/19/2026 | View on SEC |
| 4 | 5/14/2026 | View on SEC |
| 4 | 5/14/2026 | View on SEC |
| 4 | 5/14/2026 | View on SEC |
| 144 | 5/13/2026 | View on SEC |
| 144 | 5/13/2026 | View on SEC |
| 144 | 5/13/2026 | View on SEC |
| 4 | 5/11/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | RCKT |
| Company Name | ROCKET PHARMACEUTICALS, INC. |
| CIK | 1281895 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 646-440-9100 |